We have collected information about Cell Based Delivery for you. Follow the links to find out details on Cell Based Delivery.
https://bciq.biocentury.com/companies/cell_based_delivery_inc
Cell Based Delivery said it will cease operations by May. The company ran into problems with preclinical trials of its ImPACT (Implantable Protein FACTory), an implantable technology based on human muscle engineered to deliver proteins...
https://www.sciencedirect.com/science/article/pii/S0169409X07002505
At the same time, cell based delivery systems have also been developed. These possesses a number of advantages including prolonged delivery times, targeting of drugs to specialized cell compartments and biocompatibility. Here we'll focus on erythrocyte-based drug delivery.Author: F. Pierigè, S. Serafini, L. Rossi, M. Magnani
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440443/
Apr 27, 2015 · Other Cell-based Drug Carrier. Tumor tissue is some kind of inflammatory site so that immune cells, such as macrophages, neutrophils, lymphocytes, can be recruited and accumulated into tumor 19, 93-95. The unique property of these cells was used as 'Trojan horse' delivery …Author: Songwei Tan, Tingting Wu, Dan Zhang, Zhiping Zhang
https://www.bizapedia.com/ri/cell-based-delivery-inc.html
Cell Based Delivery, Inc. is a Rhode Island Foreign Corporation. The company's filing status is listed as Active and its File Number is 000097140 . The Registered Agent on file for this company is Thomas P. Mathers and is located at 4 Richmond Square, Providence, RI 02906.Location: Delaware (DE)
http://www.thno.org/v05p0863.htm
It's necessary to carefully choose SC type in designing the SC-based delivery system. Other Cell-based Drug Carrier. Tumor tissue is some kind of inflammatory site so that immune cells, such as macrophages, neutrophils, lymphocytes, can be recruited and accumulated into tumor[19, 93-95].Author: Songwei Tan, Tingting Wu, Dan Zhang, Zhiping Zhang
https://stemcellsjournals.onlinelibrary.wiley.com/doi/full/10.1002/sctm.18-0024
The development of mesenchymal stem cells (MSCs) as cell‐based drug delivery vectors for numerous clinical indications, including cancer, has significant promise. However, a considerable challenge for effective translation of these approaches is the limited tumor tropism and broad biodistribution observed using conventional MSCs, which raises concerns for toxicity to nontarget peripheral tissues (i.e., the …
https://link.springer.com/article/10.1007/s12274-018-2179-5
Sep 03, 2018 · Cell-based drug delivery systems for biomedical applications. Abstract. Spurred by numerous achievements in nanoscience and nanotechnology, the evolution of nanoparticulate drug delivery systems (nano-DDSs) is in its rapid growth period and attracting considerable attention due to their unique advantages in biomedical applications.Author: Teng Li, He Dong, Can Zhang, Ran Mo
https://www.ncbi.nlm.nih.gov/pubmed/29193876
Cell functionalization with recently developed various nano- and microcarriers for therapeutics has significantly expanded the application of cell therapy and targeted drug delivery for the effective treatment of a number of diseases.Author: Alexander S. Timin, Maxim M. Litvak, Dmitry A. Gorin, Dmitry A. Gorin, Dmitry A. Gorin, Elena N. Ato...
https://www.researchgate.net/publication/230571208_Cell-based_drug-delivery_platforms
Cell-based drug-delivery platforms. Cell systems have recently emerged as biological drug carriers, as an interesting alternative to other systems such as micro- and nano-particles. Different cells, such as carrier erythrocytes, bacterial ghosts and genetically engineered stem and dendritic cells …
Searching for Cell Based Delivery?
You can just click the links above. The data is collected for you.
